Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sabine Weibrecht
Observed name:
S. Weibrecht
Institution:
Hospital of the Brothers of St. John of God
Observed institutions:
Hospital of the Brothers of St. John of God,
Hospitaller Order of St. John of God, Austrian Province
ORCID:
0009-0001-9904-1720
Observed ORCID:
0009-0001-9904-1720
OpenAlex ID:
A5076162968
Real-world Evidence for Enfortumab Vedotin in Patients with Metastatic Urothelial Cancer: An Austrian Multicentre Study
2024
·
Dora Niedersuess-Beke
, Karl Mayrhofer
, et al.
·
Clinical Genitourinary Cancer
·
20
PDF
Enfortumab vedotin plus pembrolizumab in treatment‐naïve metastatic urothelial carcinoma patients: An Austrian real‐world analysis
2025
·
Dora Niedersuess‐Beke
, Karl Mayrhofer
, et al.
·
International Journal of Cancer
·
6
PDF
5-FU based chemotherapy with bevacizumab in synchronous metastatic colorectal cancer patients with bleeding primary tumor.
2016
·
Birgit Gruenberger
, Patrick Starlinger
, et al.
·
Journal of Clinical Oncology
·
1
Treatment, tolerability and outcomes of enfortumab vedotin plus pembrolizumab in advanced urothelial carcinoma: An analysis of the Austrian enfortumab registry.
2025
·
Dora Niedersuess -Beke
, Renate Pichler
, et al.
·
Journal of Clinical Oncology
PDF
P-161 5-FU based chemotherapy with Bevacizumab in synchronous metastatic colorectal cancer patients with bleeding primary tumor
2016
·
B. Gruenberger
, P. Starlinger
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
5
Citation count:
27
H-index:
2
I10-index:
1
Year
Topic
Type